AFT PHARMACEUTICAL LTD Logo
NZAFTE0001S4
A2DVUC
AFT.NZ

AFT PHARMACEUTICAL LTD

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2026, AFT PHARMACEUTICAL LTD has already paid €0.0147 in dividends. The last payout was in July.

Financials

In the last quarter, AFT PHARMACEUTICAL LTD had revenue of €69.99m and net profit of €5.72m
(EUR) March 2026
YoY
Revenue 69.99m -
Gross profit 30.48m -
Net profit 5.72m -
EBITDA 10.7m -

Fundamentals

Metric Value
Market capitalization
€231.52m
Number of shares
104.87m
52-week high/low
€2.53 - €1.66
Dividend yield
0.66%
Dividends TTM
€0.0147
Beta
0.43
P/E ratio
31.97
PEG ratio
1.92
P/B ratio
4.30
P/S ratio
1.86

Company profile

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

Name
AFT PHARMACEUTICAL LTD
CEO
Hartley Atkinson
Headquarters Auckland, auk
New Zealand
Website
IPO
21/12/2015
Employees 126

Ticker symbols

Exchange Symbol
Nze
AFT.NZ
Australian Securities Exchange Ltd
AFP.AX
🍪

Parqet  uses cookies. Learn more